Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
7.76
+0.06 (0.78%)
At close: Nov 13, 2026, 4:00 PM EST
7.55
-0.21 (-2.71%)
After-hours: Nov 13, 2026, 7:30 PM EST
Avalo Therapeutics Employees
Avalo Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 10 or 43.48% compared to the previous year. That makes Avalo Therapeutics the 36,821st largest employer in the world and 5,067th in the United States.
Employees
33
Change (1Y)
10
Growth (1Y)
43.48%
Revenue / Employee
$1,788
Profits / Employee
-$2,686,455
Market Cap
448.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 33 | 10 | 43.48% | 33 | 0 |
| Dec 31, 2024 | 23 | 4 | 21.05% | 23 | 0 |
| Dec 31, 2023 | 19 | -1 | -5.00% | 19 | 0 |
| Dec 31, 2022 | 20 | -24 | -54.55% | 20 | 0 |
| Dec 31, 2021 | 44 | 13 | 41.94% | 42 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Assembly Biosciences | 73 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Shattuck Labs | 40 |
| DiaMedica Therapeutics | 35 |
AVTX News
- 4 days ago - Avalo Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 6 days ago - Avalo Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 9 days ago - Avalo Therapeutics price target lowered to $20 from $22 at Wedbush - TheFly
- 9 days ago - Avalo Therapeutics price target lowered to $24 from $29 at BofA - TheFly
- 10 days ago - Avalo Therapeutics files automatic mixed securities shelf - TheFly
- 10 days ago - Avalo Therapeutics reports Q3 EPS (34c), consensus (55c) - TheFly
- 10 days ago - Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates - GlobeNewsWire
- 10 days ago - Avalo Therapeutics Quarterly report: Q3 2026 - Filings